With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
"What's going on now is an attempt to bridge this gulf -- to harness the capitalist incentives that drive the drug companies and make them work for the world's poorest people, while preserving the idealism at the heart of the field of public health. It is a grand experiment, and while preliminary signs suggest it could work, the case is far from proven.
...Much of the difficulty, it turned out, was with the public-health community: Hobbled by spotty funding and poor strategic planning, health advocates couldn't forecast how much of a given vaccine they would be able to buy for the poor countries. In the face of uncertain demand, companies would hesitate to spend extra millions to build big factories, scaling their plants only for the industrial world. In these smaller plants, the companies would never achieve the economies of scale needed to drive production costs down, which meant they couldn't afford to sell their vaccines to poor countries at low prices.
..."I still go to meetings where people will say to me, 'We have to lobby the companies to lower their prices,' " said Orin Levine, a public-health doctor at Johns Hopkins University who heads a Gates-backed initiative for pneumonia vaccines. "I say, 'You can lobby them till the cows come home. What we really need to do is help them build a convincing business case that they should be in this market.' "
Last week, Gavi, the Vaccine Alliance, completed a $7.5 billion replenishment to fund its work on immunization in the world’s poorest countries between now and 2020. Gavi’s next step is to ensure that the money is used as effectively as possible to save lives and improve health.
The majority of the world’s sick live in middle-income countries (MIC) – mainly Pakistan, India, Nigeria, China and Indonesia (or PINCI), according to new data from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Sound familiar? Andy Sumner, Denizhan Duran, and I came to the same conclusion in a 2011 paper, but we used 2004 disease burden data, which didn’t provide an up-to-date view of reality. So I was pleased to see that our findings still hold based on IHME’s 2010 Global Burden of Disease (GBD) estimates.